Different Tumor-Derived p53 Mutants Exhibit Distinct Biological Activities
- 5 October 1990
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 250 (4977) , 113-116
- https://doi.org/10.1126/science.2218501
Abstract
In its wild-type form, the protein p53 can interfere with neoplastic processes. Tumor-derived cells often express mutant p53. Full-length mutant forms of p53 isolated so far from transformed mouse cells exhibit three common properties in vitro: loss of transformation-suppressing activity, gain of pronounced transforming potential, and ability to bind the heat shock protein cognate hsc70. A tumor-derived mouse p53 variant is now described, whose site of mutation corresponds to a hot spot for p53 in human tumors. While absolutely nonsuppressing, it is only weakly transforming and exhibits no detectable hsc70 binding. The data suggest that the ability of a p53 mutant to bind endogenous p53 is not the sole determinant of its oncogenic potential. The data also support the existence of gain-of-function p53 mutants.This publication has 21 references indexed in Scilit:
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Analysis of BCR‐ABL mRNA in chronic myelogenous leukemia patients and identification of a new BCR‐related sequence in human DNAGenes, Chromosomes and Cancer, 1989
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- The p53 proto-oncogene can act as a suppressor of transformationCell, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- When the products of oncogenes and anti-oncogenes meetCell, 1989
- Specific interaction between the p53 cellular tumour antigen and major heat shock proteinsNature, 1986
- Co-operation between the p53 protein tumor antigen and platelet-poor plasma in the induction of cellular DNA synthesisExperimental Cell Research, 1986
- Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 geneCell, 1984
- Isolation of a transforming sequence from a human bladder carcinoma cell lineCell, 1982